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Cervical lymphadenopathyAbstract Introduction: Diffusion weighted magnetic resonance imaging (DW MRI) is an imaging
technique showing molecular diffusion. Cell size, density and integrity inﬂuence the signal intensity
seen on diffusion-weighted images. This technique is a helpful complementary tool to distinguish
tumoral from non tumoral tissue.
The aim of this prospective study is to deﬁne the diagnostic accuracy of DWI to differentiate benign
from malignant cervical lymph nodes.
Patients and methods: Twenty six patients who presented with 32 nodes were included in this study,
9 males (35.6%) and 17 females (65.4%). Their age ranged from: 6 to 76 years, mean age
45 ± 18.8 years referred to the radiology department of NCI, complaining of neck swelling, ultra-
sound showed cervical nodes.
Results: According to histopathological analysis we divided the examined lymph nodes (n= 32)
into 2 categories: malignant lymph nodes 75% (n= 24) benign lymph nodes 25% (n= 8). DWI
and ADC (apparent diffusion coefﬁcient) values revealed 27 malignant lesions (84%), 5 benign
(16%). The accuracy of the DWMRI was 89%. A signiﬁcant difference between benign and malig-
nant cervical nodes on DWI and on ADC maps is reported.
The results obtained were 24 true positive, 3 false positive, 5 true negative. No false negative cases
were identiﬁed, yielding a sensitivity of 100%, speciﬁcity of 62.5%, NPV= 100% and
PPV = 89%. The difference between the mean ADC values between benign and malignant lesions
was statistically signiﬁcant (P< 0.0001).
Conclusion: MR diffusion imaging could be an important supportive tool in differentiation
between benign and malignant lymph nodes, can to a lesser extent differentiate between the types
1116 Noha Abd ElShafy ElSaid et al.of malignant lymphadenopathy and can be used as an indicator for improvement and recurrence
post chemo and radiotherapy.
 2014 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier
B.V.Open access under CC BY-NC-ND license.1. Introduction
Lymphadenopathy is an abnormal increase in size and/or
altered consistency of the lymph nodes. The condition is gener-
ally not a disease by itself, rather, it may be a symptom of one of
many possible underlying problems and serves as an excellent
clue to them. It could be due to infections, autoimmune disor-
ders or malignancies (metastatic or lymphomas) (1).
Nodal metastases are an adverse prognostic factor in
patients with head and neck squamous cell carcinoma
(HNSCC) not only for the planning of appropriate treatment
but also for monitoring the treatment response. Imaging is
used in addition to clinical evaluation to improve the detection
of nodal metastases (2).
In case of lymphoma, DWI could be used not only in a
pre-treatment phase, but also after therapy to detect recurrent
disease or as sign of improvement (3).
Small lymph nodes with a maximum short axial diameter
below 10 mm are more challenging for radiologists, because
the mere use of this size criterion will result in misclassiﬁcation
of malignant lymph nodes as normal on MRI evaluation (2).
Diffusion-weighted magnetic resonance imaging (DWMRI)
is an imaging technique showing molecular diffusion. Cell size,
density and integrity inﬂuence the signal intensity seen on dif-
fusion-weighted images. This technique is a helpful comple-
mentary tool to distinguish tumoral from non-tumoral tissue,
and has several interesting applications in the evaluation of
head and neck cancer especially in head and neck lymphade-
nopathy (4).
Although diffusion-weighted MRI (DWI) has been used for
some time for brain evaluation, extra cranial applications of
diffusion-weighted (DW) magnetic resonance (MR) imaging
are gaining importance. DWI is able to characterize tissue
based on differences in water mobility (5).
Hypercellular tissue, such as occurring within malignant
tumors, will show low ADC values. Non-tumoral tissue
changes such as edema, inﬂammation, ﬁbrosis, and necrosis
are expected to show low cellularity, in strong contrast with
viable tumor. This results in a high ADC. An inverse correla-
tion between the ADC value and tumor cellularity in experi-
mental models has been shown, and this has been clinically
validated (3).
Differentiation of treatment-induced tissue changes, espe-
cially after chemo and/or radiotherapy, and persistent or
recurrent cancer, is another area in which DWI may be very
helpful. As DWI allows differentiation between inﬂammatory
and neoplastic tissues, another possible application could be
the monitoring of tumor response during radiotherapy: this
could have prognostic importance and possibly inﬂuence the
management of the patient (2).
The aim of this prospective study is to deﬁne the diagnostic
accuracy of DWI to differentiate benign from malignant
cervical lymph nodes.2. Patients and methods
2.1. Patients
Our prospective study cohort included 26 patients with
palpable 32 neck nodes, 9 males (35.6%) and 17 females
(65.4%). Their age ranged from 6 to 76 years, mean age
45 ± 18.8 years.
All the patients were referred from the outpatient clinics to
the radiology department in National cancer institute. Eleven
patients presented with palpable cervical lymph nodes with
unknown primary. They underwent neck US or CT before
MRI examination. Ten patients with known head and neck
cancer underwent MRI for staging and therapy planning. Five
patients were coming for routine follow up post total thyroid-
ectomy and radioactive iodine therapy.
Moreover we studied 1 patient with Hodgkin lymphoma
after chemotherapeutic treatment. Follow up DWI was done
in this case; comparison regarding the size of LN and ADC
was performed. Biopsy was done in this case and revealed
good therapeutic response.
 Inclusion criteria
- Patients presenting with enlarged cervical lymph nodes as a
ﬁrst presentation or with known head and neck cancer.
 Exclusion criteria
- Patient who has one or more of the absolute or relative
MRI contraindications i.e. patient with one or more of
the following:
1. Electronically, magnetically and mechanically activated
implants.
2. Ferromagnetic or electronically operated active devices.
3. Cardiac pacemakers.
4. Metallic splinters in the eye.
5. Ferromagnetic hemostatic clips in the central nervous
system (CNS).
6. Cochlear implants.
7. Insulin pumps and nerve stimulators.
8. Prosthetic heart valves (in high ﬁelds, if dehiscence is
suspected).
2.1.1. Patients were subjected to the following
Full clinical assessment including recording of age, sex and
clinical presentation.
Laboratory investigations [coagulation proﬁle, renal func-
tion tests (blood urea and serum creatinine)].
MRI neck (pre- and post contrast study and diffusion-
weighted imaging) results were compared to histopathology
results in all patients.
US guided biopsies were done for the suspicious cervical
lymph nodes in 22 patients in our study, only 4 patients under-
went excisional biopsies after taking the patient’s consent.
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body system (Intera NT; Philips Medical Systems, Best, the
Netherlands) with a 30 mT/m maximum gradient capability
in NCI. A standard receive-only head and neck coil was used
for both conventional imaging and diffusion-weighted MR
imaging to include nodes from the base of the skull to the
suprasternal notch.
In all patients, the protocol included:
- Fast spin echo (FSE) T2-weighted images (TR 2500–
4500 ms, TE 80 ms, slice-thickness: 5 mm) in axial plane;
with no intersection gap; number of signals acquired 4,
Voxel size: RL 0.9, AP 1.1.
- Fast spin echo (FSE) T2-weighted images (TR 3850 ms, TE
75 ms, slice-thickness: 5 mm), in coronal plane.
- Fast spin echo (FSE) T1-weighted images, with and with-
out fat suppression (TR 400–650 ms, TE 14 ms, slice-thick-
ness: 5 mm) in axial plane; with no intersection gap;
number of signals acquired 4, Voxel size: RL 0.9, AP 1.1.
- Fast spin echo (FSE) T1-weighted images, with fat suppres-
sion SPAIR: (Spectral Attenuated Inversion Recovery)
after contrast medium administration of 0.1 mmol/kg of
Omniscan (gadodiamide), GE Healthcare); in axial and
coronal planes.
Diffusion-weighted MR imaging was performed before the
contrast-enhanced T1-weighted MR imaging sequence using
a spin-echo single shot T2 weighted echo-planar imaging
sequence with the following parameters:
2000/75; section thickness, 4 mm, with no gap; ﬁeld of view,
230 mm; acquisition matrix, 112 · 112; reconstruction matrix,
256 · 256; pixel resolution of 2.0 · 2.0 · 4.0 mm.
Diffusion gradient encoding in three (x, y, z) orthogonal
directions.
b values were of 0, 1000 s/mm2. At each b value, x, y, and z
single-direction DW images and a baseline image (b _ 0 s/mm2)
were acquired; combined ([x _ y _ z]/3). DW imaging was per-
formed and calculated automatically by the MR instrument.
11 fat-suppressed diffusion-weighted MR images in the head
and neck were acquired in the transverse plane.
Parallel imaging with generalized auto-calibrating partially
parallel acquisition (GRAPPA) with an acceleration factor of
two was applied to improve image quality.
All DW imaging data were transferred to a computer work-
station for determination of the signal intensity and ADC
(apparent diffusion coefﬁcient). The ADC map was automati-
cally reconstructed by a standard software imager in the main
console. The ADC was measured by manually placing regions
of interest on the ADC map. The ADC was measured twice
and the two measurements were averaged. To ensure that the
same areas were measured, regions of interest were copied
and pasted from DW images to ADC maps. In the study, we
chose only the largest abnormal adenopathies and excluded
from analysis the necrotic areas.
2.1.2. Imaging analysis
The lymph nodes were characterized on the basis of interna-
tionally accepted standards for evaluating anatomic imaging
data. First, the morphological features of each lymph node
of interest were recorded such as the size (in shortest axial
diameter), parenchymal homogeneity, areas of necrosis andnodal contour irregularity. The above ﬁndings could be
detected in conventional T1-weighted, T2-weighted, and con-
trast material-enhanced T1-weighted images. SI in T1 and T2
WIs gives an idea about nodal activity as well as its contrast
uptake (the malignant nodes show more contrast
enhancement).
Second, the DW images and their corresponding ADC
map were analyzed in consensus at a picture archiving and
communication system workstation. The lymph nodes were
localized on the images obtained with a b value of 0 s/mm2.
For quantitative assessment, regions of interest were placed
in the lymph nodes identiﬁed on the b _ 0 images, and the soft-
ware automatically copied these regions onto the other b value
images. For the entirely solid lymph nodes, the regions of
interest were placed over the entire lymph node. In cases of
obvious solid and necrotic components depicted on the
conventional MRI, regions of interest were placed on the solid
tissue portions.
Finally, the histopathology and radiologic ﬁndings were
correlated – as a reference standard – after all image interpre-
tations had been concluded. The optimal ADC b0-1000 thresh-
old for differentiating a benign from a malignant lymph node
was determined by using receiver operating characteristic anal-
ysis. The sensitivity, speciﬁcity, and accuracy of the ADC b0-
1000 were subsequently calculated.
We depend in our study on both the ADC value and signal
intensity in evaluating the affected lymph node.
3. Statistical analysis
Data were statistically described in terms of mean ± standard
deviation (±SD), and range, or frequencies (number of cases)
and percentages when appropriate. Comparison of numerical
variables between the study groups was done using Student’s
t test for independent samples. For comparing categorical
data, Chi square (v2) test was performed. Exact test was used
instead when the expected frequency is less than 5. Accuracy
was represented using the terms sensitivity, and speciﬁcity.
Receiver operator characteristic (ROC) analysis was used to
determine the optimum cut off value for the studied diagnostic
markers. P values less than 0.05 were considered statistically
signiﬁcant. P value >0.05 was considered insigniﬁcant.
P value <0.05 was considered signiﬁcant.
P value <0.01 was considered highly signiﬁcant.
All statistical calculations were done using computer pro-
grams SPSS (Statistical Package for the Social Science; SPSS
Inc., Chicago, IL, USA) version 15 for Microsoft Windows.
4. Results
The pool of this study was 26 patients and the results were ana-
lyzed as follows.
4.1. Patients’ characteristics
26 patients were included in this study, 9 males (35%) and 17
females (65%) (Table 1). Their age ranged from: 6–76 years,
mean age 45 ± 18.8 years.
Table 1 Age and sex distribution according to histopathological diagnosis.
Case diagnosis Gender Age
Male: N Female: N Mean (SD)
Acute lymphocytic leukemia 1 – 9
Hodgkin lymphoma 2 – 11 (7.07)
Non Hodgkin lymphoma 1 2 68 (8.08)
Metastatic diﬀerentiated carcinoma 3 6 53 (7.83)
Metastatic undiﬀerentiated carcinoma 1 3 55 (10.8)
Acute Reactive lymphadenitis 1 – 16
Chronic granulomatous inﬂammation – 1 35
Chronic non speciﬁc inﬂammation – 2 31 (6.36)
Reactive lymphoid hyperplasia – 3 44 (11)




Malignant 0.567–0.98 0.774 0.11
Benign 0.712–1.3 1.019 0.20
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Histopathological analysis was done dividing the examined
lymph nodes in our study (n= 32) into 2 categories:
(A) Malignant lymphadenopathy 75% (n = 24) subdivided
as follows; acute lymphocytic leukemia (n= 2), Hodgkin lym-
phoma (n= 2), Non Hodgkin lymphoma (n= 4), metastatic
differentiated carcinoma (n= 10), metastatic undifferentiated
carcinoma (n= 6) and (B) benign lymphadenopathy 25%
(n = 8) subdivided into acute reactive lymphadenitis
(n= 1), chronic granulomatous inﬂammation (n= 1), chronic
non speciﬁc inﬂammation (n= 2) and reactive lymphoid
hyperplasia (n= 4).
4.3. MRI diagnosis according to recorded ADC values
DWI and ADC values revealed 27 malignant lesions (84%), 5
benign (16%) the accuracy of the MRI was 89% in our study.
4.4. Image evaluation
1- Conventional MRI (T1 and T2 weighted images): for
size and parenchymal architecture evaluation of the
lymph nodes.
 Size criteria among the benign and malignant LNs (in
shortest axis diameter).
The size of the examined lymph nodes (n= 32) ranged
from 0.6 to 2.5 cm (mean size 1.2 ± 0.44 cm).
23 nodes were 1 cm or more in diameter; 17 malignant and
6 benign LNs while 9 nodes were less than 1 cm in diameter; 7
malignant and 2 benign LNs. Ratio between the longest and
shortest axial diameter was 1.5:1.
4.5. Parenchymal architecture among the benign and malignant
LNs
Among the malignant lymphadenopathy group (n= 24), 19
nodes exhibited homogenous solid architecture (79.2%) and
5 nodes exhibited heterogeneous architecture of the paren-
chyma (20%). Among the benign lymphadenopathy group
(n= 8), all nodes exhibited homogenous solid architecture of
the parenchyma (100%). These changes in nodal architecture
were well depicted on T2-weighted images.
2- Diffusion WIsAll malignant nodes (n= 24) show restricted diffusion evi-
denced by increased signal on increasing the b-values
(b= 1000) and low signal on ADC maps. In 5/8 cases with
inﬂammatory diseases, lymph nodes showed reduction of
signal intensity on increasing b values (b= 1000) and interme-
diate signal intensity on ADC maps reﬂecting facilitated
diffusion. 3/8 cases of benign lymphadenopathy, diagnosed
as reactive lymphoid hyperplasia and chronic granulomatous
infection show increased signal on increasing b-values (false
positive).
3- ADC values among the malignant and benign LNs
 ADC values were obtained and recorded for all 32 cervical
lymph nodes detected at consensus reading.
(A) Malignant lymph node group
ADC values of the malignant lymph (n= 24) ranged
between 0.567 and 0.98 · 103 mm2/s (Table 2). The mean
ADC value of malignant lymph nodes was 0.774 ± 0.11 ·
103 mm2/s.
Among the subgroups of malignant lymph nodes: The
mean ADC value of metastatic differentiated carcinoma
(0.83 · 103 mm2/s) was slightly higher (i.e., less restricted)
than the mean ADC values of undifferentiated carcinoma
(0.811 · 103 mm2/s), Hodgkin lymphoma (0.734 · 103 mm2/s)
and non Hodgkin lymphoma (0.686 · 103 mm2/s) in the
descending order. There were no statistically signiﬁcant
differences in ADC values among the different subgroups of
malignant lymph nodes.
The patient with Hodgkin disease who received chemother-
apy, had undergone follow up DW MRI, lymph nodes were
hypointense on DWI (b= 1000) and intermediate signal on
the ADC maps with a mean ADC value of 1.2 · 10–3 mm2/s
(compared to ADC 0.687 · 10–3 mm2/s pretreatment)
indicating facilitated diffusion.
Table 3 ADC–pathology correlation.
Frequency Percentage (%)
True positive 24 75
False positive 3 9.4
True negative 5 15.6
Total 32 100
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ADC values of benign lesions ranged between 0.712 · 103
and 1.3 · 103 mm2/s (Table 2). The mean ADC value of the
benign lymph nodes (n= 8) was 1.019 ± 0.20 · 103 mm2/s.
The highest mean ADC value was for acute lymphadenitis.
Among the benign lesions, chronic granulomatous inﬂamma-
tion (n= 1) and reactive lymphoid hyperplasia (n= 3) had
low ADC values similar to the malignant group.
The mean ADC value of malignant nodes was lower than
the mean ADC value of benign nodes. The difference between
the mean ADC values of benign and malignant lesions was sta-
tistically signiﬁcant (P< 0.0001).
A threshold ADC value for differentiating malignant from
benign nodes derived with receiver operating characteristic
analysis equals 1.005 · 10–3 mm2/s (Fig. 1).
The statistical data obtained were 24 true-positive, 3 false-
positive, 5 true-negative ﬁndings, yielding 100% sensitivity,
62.5% speciﬁcity%, NPV = 100% and PPV = 89% (Table 3).
5. Discussion
Diffusion weighted imaging (DWI), a well-known MRI-
technique in neuroradiology, has shown its potential to be a
reliable non-invasive imaging technique for tissue characteriza-
tion. DWI exploits the random motion of water in the targeted
tissue, which reﬂects the tissue speciﬁc diffusion capacity.
Thus, the diffusion capacity can be used for tissue character-
ization. In biologic tissues, the diffusivity of water molecules
is conﬁned by the intra-cellular and inter-cellular spaces.
Hyper cellular tissue, such as malignant tumors, results inFigure 1 Receiver operating characteristic (ROC) curve of the
ADC values used for differentiating benign from malignant lymph
nodes. The area under the curve of 0.828. We obtained the
threshold ADC value for differentiating benign from malignant
nodes from this ROC curve = 1.005 · 103 mm2/s.decreased mobility of water protons and consequently in a
restricted diffusion capacity of the tissue. Thus, tumors present
with increased signals on DWI and low ADC values. Non-
tumoral tissues such as edema, inﬂammation, ﬁbrosis, and
necrosis are expected to show low cellularity–in strong contrast
with viable tumor. In these tissues the diffusion capacity is not
restricted. This results consecutively in a signal loss on DWI
and in a high ADC (6). The evaluation of cervical adenopa-
thies is important as they serve as an excellent clue to underly-
ing problems. They could be due to infections, autoimmune
disorders or malignancies (metastatic or lymphomas) (1).
Ultrasound image, contrast-enhanced computed tomo-
graphic and contrast-enhanced MRI allow the detection of
enlarged cervical lymphadenopathies. None of these methods
reaches the ideal accuracy in diagnosis (14). These imaging
methods use standard parameters (shape, size, internal archi-
tecture, extranodal diffusion and vascular features). The size
is the most used criterion for the diagnosis (3). The criterion
of a short-axis diameter of 10 mm has gained widespread
acceptance (2) and thus used in our study. To date, the diagno-
sis of lymph node metastases is based mainly on size criteria;
however, non enlarged nodes may harbor malignancy, whereas
reactive nodes may be enlarged. Promising results with DW
imaging to help detect cervical lymph node metastases and dif-
ferentiate between benign and malignant enlarged nodes have
been reported by (5). Other criteria have proven to be unreli-
able as internal necrosis because they may also be detected
in non-metastatic disease including inﬂammation, infection
and autoimmune disease (6).
SPECT (single photon emission CT) and PET (photon
emission tomography) are new imaging techniques which
supply functional information (blood ﬂow and glucidic
metabolism) but they are invasive (exposure to radiations),
expensive, not easily available and with a relatively low spatial
resolution (15).
First results were obtained by (7) from lymph nodes of the
head and neck region using a navigated DW-EPI with a b
factor of 0 s/mm2 and 800 s/mm2. Regular (benign) lymph
nodes showed signiﬁcantly higher diffusivity than that of
metastatic lymph nodes.
Our study had been conducted on 26 patients, mean age
was 45 ± 18.8 years. The prevalence of Hodgkin disease
(n= 2) and leukemia (n= 1) was higher in young age groups;
mean age in HD and leukemic patients was 11 and 9 years
respectively while the prevalence of non Hodgkin disease
(n= 3) was higher among the elderly age group; mean age
was 68 years. Otherwise, there is no signiﬁcant difference
according to age or gender of patients.
In this study, DW imaging with the use of ADCb0-1000
values had high accuracy in the detection of metastatic lymph
nodes, mainly by improving the detection of subcentimeter
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its shortest axis diameter; 7/9 were metastatic – and showed
restricted pattern on DWIs and corresponding low ADC value
– on the other hand, these 9 nodes show no distinctive mor-
phologic features of malignancy, such as necrosis and indis-
tinct margins in conventional MRI and differentiation of
metastatic nodes would have been quite impossible. These
results were in line with other studies, (2) stated that nearly
all metastatic lymph nodes smaller than 1 cm were missed
owing to the size-based criteria for anatomic MR imaging.
Therefore, it has been concluded that DW imaging could pro-
vide additional value to an anatomic MR examination, espe-
cially in subcentimeter-sized lymph nodes. Several factors
enable the detection of small nodal metastases at DW imaging.
Use of improved echo-planar imaging technology, dedicated
coils, and dedicated sequence optimization enables a maximal
reduction of echo-planar imaging-related artifacts at a
relatively high spatial resolution.
De Bondt et al., (16) also concluded that with predomi-
nantly small lymph nodes, the ADC criterion is the strongest
independent predictor of the presence of metastasis. The use
of ADC values in combination with the other MRI criteria sig-
niﬁcantly improves the discrimination between malignant and
benign lymph nodes with a sensitivity and speciﬁcity 92.3%
and 83.9% respectively.
In our study, 3/10 metastatic differentiated squamous cell
carcinomas lymph nodes (<1 cm) were detected on the contra-
lateral side to the primary tumor (postcricoid, lip SCC)
whereas 1/10 node (1 cm) detected on the contralateral side
of the primary tumor (retromolar cancer) had proven benign.
These ﬁndings had been stated in the literature, (8) reported
the degree to which DW imaging changes the accuracy of
nodal differentiation, by depicting subcentimeter nodal metas-
tases which may affect the clinical management in speciﬁc sit-
uations. In cases of head and neck tumors growing close to the
midline or extensive ipsilateral nodal metastatic involvement,
the detection or exclusion of metastatic spread to the contra-
lateral neck is pivotal to treatment. As such, the technique
has potential value as an ancillary tool for not only determin-
ing the extent of neck dissection required for advanced stage
disease but also planning radiation therapy.
Use of this technique also improved the identiﬁcation of
benign enlarged lymph nodes. Our study included 23 nodes
of 1 cm or more in shortest axial diameter; and 6/23 were
benign inﬂammatory LNs with non restricted pattern.
This study was conducted with high b value (b= 1000
s/mm2) to overcome the effect of capillary perfusion and water
diffusion in extracellular extravascular space, as high b value
will result in the reduction of signal from moving protons in
vessels. Using higher b-values, thus, will improve the speciﬁcity
of the contrast on DWI. Furthermore, the differences in the
relative contrast ratio between malignant and benign lesions
were increased with a high b value. This was similar to the b
values used in studies carried out by (2,9,3).
In our study, all malignant nodes (n= 24) show restricted
diffusion evidenced by increased signal on increasing the b-val-
ues (b= 1000) and low signal on ADC maps. 5/8 cases with
inﬂammatory diseases, lymph nodes showed reduction of
signal intensity on increasing b values and intermediate signal
intensity on ADC maps reﬂecting facilitated diffusion
(b= 1000). These data are similar to those in the literature,
(3,2) reported that metastatic and lymphomatous nodespresent a reduction of diffusivity, which can be attributed to
a hypercellularity, cellular pleomorphism, increased mitosis
and nuclear-to-cytoplasmatic ratio. These features probably
diminish the extracellular extravascular space.
These results are in line with (17) who concluded that DWI-
MRI performed with ADC values shows signiﬁcant differences
among malignant nodes, lymphomatous nodes, and benign
nodes in cervical lymphadenopathy.
In our study, the difference between the mean ADC values
of benign and malignant lesions was statistically signiﬁcant
(P< 0.0001) which was in line with (2) which reported that
the mean ADC value derived from the signal intensity across
images (ADC b0-1000) of benign lymph nodes was higher than
that of malignant LNs and these differences were statistically
signiﬁcant (P < 0.0001). Perronea (3) reported that ADC val-
ues of benign lymph nodes were signiﬁcantly higher than those
of malignant LNs, with a P value <0.01 and the mean ADC
value for malignant lesions, that was 0.85 · 10–3 mm2/s, which
is lower than that of benign LNs, that was 1.448 · 10–3 mm2/s.
The best ADC threshold value for distinguishing benign from
malignant nodes was 1.03 · 10–3 mm2/s, with a sensitivity of
100% and a speciﬁcity of 92.9%.
The best threshold for differentiating malignant from
benign lymph nodes was 1.15 · 10–3 mm2/s (18).
Holzapfel et al. (9) reported an accuracy of 94% in charac-
terizing metastatic lymph nodes when using a threshold of
1.02 · 10–3 mm2/s. Their reported mean ADC values for
benign and metastatic lymph nodes were 1.24 ± 0.16 · 10–
3 mm2/s and 0.78 ± 0.09 · 10–3 mm2/s, respectively.
In our study, the mean ADC value of the 24 malignant
lymph nodes was 0.774 ± 0.11 · 103 mm2/s whereas the
mean ADC value of the 8 benign lymph nodes was
1.019 ± 0.20 · 103 mm2/s with a threshold ADC value for
differentiating malignant from benign nodes derived with
receiver operating characteristic analysis of 1.005 · 10–3 mm2/
s with a sensitivity of 100% and a speciﬁcity of 62.5%.
In our study, one patient with Hodgkin disease who
received chemotherapy, had undergone follow up DW MRI,
lymph nodes were hypointense on DWI (b= 1000) and inter-
mediate signal on the ADC maps with a mean value of
1.2 · 10–3 mm2/s (compared to ADC 0.687 · 10–3 mm2/s pre-
treatment) indicating facilitated diffusion. This ﬁnding was in
line with previous studies.
Thoeny et al. (5) reported that after chemotherapy or radi-
ation therapy, residual changes or even masses are commonly
observed at the primary or nodal site, and conventional
morphologic MR imaging currently encounters difﬁculty in
helping distinguish between benign post treatment alterations
and residual cancer.
Studies done by (10) showed that the ADC of residual or
recurrent squamous cell carcinoma is signiﬁcantly lower than
that of a post treatment non tumoral residual mass, and simi-
lar ADC thresholds of around 1.3 mm2/s have been identiﬁed
in these studies.
In our study, malignant lymph nodes were subdivided
according to histopathology into subgroups: metastatic differ-
entiated carcinoma, metastatic undifferentiated carcinoma,
Hodgkin and non Hodgkin lymphoma. An attempt to differ-
entiate between them on basis of their ADC values was made.
The mean ADC value of metastatic differentiated carcinoma
(0.83 · 103 mm2/s) was slightly higher (i.e., less
restricted) than the ADC value of undifferentiated carcinoma
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and non Hodgkin lymphoma (0.686 · 103 mm2/s) in the
descending order. There were no statistically signiﬁcant differ-
ences in ADC values among the different subgroups of malig-
nant lymph nodes.
Regarding the former mentioned issue, statistically signiﬁ-
cant results were reported in the literature. King et al., (11)
reported that Diffusion-weighted MR imaging shows signiﬁ-
cant differences among malignant nodes of differentiated car-
cinoma, lymphoma, and undifferentiated carcinoma.
In our study, the statistical data obtained were 24 true-posi-
tive, 3 false-positive, 5 true-negative ﬁndings, yielding 100%
sensitivity, 62.5% speciﬁcity%, NPV = 100% and
PPV = 89%.
The false positive results were previously described by (12),
in benign lymph nodes, a false decrease in ADC may correlate
with the presence of nodal reactive changes that manifest as
multiple germinal centers and ﬁbrotic stroma, which act as
microstructural barriers. Vandecaveye et al, (2) as well
described a false decrease in ADC due to nodal reactive
changes which may lead to an overestimation of the metastatic
burden. In their study, this was reﬂected by the lower speciﬁc-
ity of DW imaging, as compared with conventional MR imag-
ing, in the detection of subcentimeter nodal metastases. The
combined use of DW imaging and anatomic features indicative
of benignity may help to decrease the false-positive rate.
Choi et al. (13) stated that other false-positive readings may
be due to restricted diffusion in recent hemorrhage or hema-
toma. Therefore, DW imaging probably should not be per-
formed directly after biopsy.
5.1. Our study had some limitations
First, our study has some limits such as being a small study
cohort.
Second, we did not report normalized ADCs for several
reasons: the beneﬁt of using normalized rather than absolute
ADCs at DW imaging of the head and neck has never been
reported. In contrast to the brain, the head and neck area is
characterized by highly heterogeneous tissue diffusivity owingAxial FSE T1 Axial FSE T2
DWIs b0-1000 :partially hyperintense
Figure 2 A 6 year old male patient presentinto the presence of tissues of a distinctly different histologic ori-
gin. Therefore, the spine is probably the most suitable refer-
ence tissue for normalization purposes. However, spinal cord
echo-planar imaging is hindered by strong susceptibility inﬂu-
ences––induced mainly by the surrounding osseous elements of
the spinal column––that introduce additional variability in
ADC calculations also the promising results of the current
study, which were achieved by using absolute ADCs, might
indicate that normalization is not mandatory, facilitating the
implementation of DW imaging into routine clinical practice.
6. Conclusion
MR diffusion imaging could be an important supportive tool
in differentiation between benign and malignant lymph nodes,
can to a lesser extent differentiate between the types of malig-
nant lymphadenopathy and can be used as an indicator for
treatment response post chemo and radiotherapy and detec-
tion of residual/recurrent pathology.
Case 1: A 6 year old male patient presenting with left sided
progressive neck swelling (Fig. 2).
MR ﬁndings: Multiple enlarged left deep cervical lymph
nodes: level IV and V of lobulated smooth contours.
Size: The largest measures 2.5 cm in its shortest transverse
diameter.
Parenchymal architecture: They show low homogenous T1
signal changing into intermediate/high T2 signal with faint het-
erogenous contrast uptake.
On DWIs: In DWIs: b0 and b1000, they are partially hyper-
intense corresponding to lymph nodes of low signal in ADC
map (restricted pattern).
ADC values: were recorded as follows
Group IV 0.825 · 103 mm2/s
Group V 0.787 · 103 mm2/sgAxial FS T1 + C
ADC : hypointense
with left sided progressive neck swelling.Suggested MR diagnosis: Malignant lymphadenopathy.
Biopsy results: Hodgkin lymphoma (nodular lymphocytic
dominance).
Axial FSE T1 Axial FSE T2 Axial FS T1 + C
DWIs b0-1000 : mixed intensity ADC: intermediate 
intensity 
Figure 3 A 16 year old male patient presenting with bilateral neck swellings of acute onset, regressive course on antibiotics.
Axial FSE T1 Axial FSE T2 Axial FS T1 + C
DWI b0 -1000: hyperintense ADC: hypointense 
Figure 4a Left metastatic undifferentiated carcinoma.
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of residual lymph nodes was 1.16 · 103 mm2/s (facilitated
pattern) indicating good therapeutic response.
Case 2: A 16 year old male patient presenting with bilateral
neck swellings of acute onset, regressive course on antibiotics
(Fig. 3).
MR ﬁndings: Bilateral enlarged upper deep cervical lymph
node level IIa showing smooth contours. The largest on the left
side measures 1.3 cm in its shortest transverse diameter. They
exhibit isointense T1 signal changing into high T2 signal with
fair homogenous contrast uptake.On DWIs: In DWIs: b0 and b1000, they are partially hyper-
intense corresponding to lymph nodes of intermediate mixed
signal in ADC map.
ADC value: 1.3 · 103 mm2/s. ROI was in the central rela-
tively hyper intense area of the node (blue arrows in ADC
image).
Suggested MR diagnosis: morphologically and by ADC
value appear to be benign lymphadenopathy.
Biopsy results: Reactive lymphadenitis.
Case 3: A 49 year old female patient presenting with left
neck swellings of insidious onset. No known primary. Neck
Axial FSE T1 Axial FSE T2 Axial FS T1+ C
DWI b0 -1000:hyperintense ADC:hypointense
Figure 4b Left metastatic undifferentiated carcinoma (lower cuts).
Diagnostic accuracy of DW MRI in cervical lymphadenopathy cases 1123US was done revealing enlarged left lower cervical lymph
nodes (Figs. 4a and b).
MR ﬁndings: Left enlarged lower deep cervical lymph
nodes: level IV and V lymph nodes with regular contour
(Fig. 4a).
Size: Shortest transverse diameter of 0.6 cm and 1 cm
respectively.Axial FSE T1 Axial FSE
DWI b0 -1000 : partially hyperint
Figure 5 A 76 year old male patient presenting with left sidParenchymal architecture: They exhibit isointense homoge-
nous T1 and intermediate T2 signals with faint contrast uptake
in post contrast series. Lower level left level IV lymph node
with partially ill deﬁned margins (Fig. 4b).
Size: shortest transverse diameter of 1.04 cm.
Parenchymal architecture: It exhibits isointense homoge-
nous T1 and intermediate T2 signals with faint contrast uptake
in post contrast series. T2 Axial FS T1 +C
ense ADC: hypointense
ed neck swellings of insidious onset. No known primary.
Axial FSE T1 Axial FSE T2 Axial FS  T1+ C
DWI b0 -1000 : hyperintense ADC: hypointense
Figure 6 A 55 year old male presenting with left sided retromolar malignant mass of insidious onset. MRI neck was done for staging.
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hyperintense corresponding to lymph nodes of low signal in
transverse ADC map. (Restricted pattern).
ADC value: (a) 0.947 · 103 mm2/s (group IV) and
0.825 · 103 mm2/s (group V), (b) 0.838 · 103 mm2/s (group
IV).
Suggested MR diagnosis: Malignant lymphadenopathy.
Biopsy results: Metastatic undifferentiated carcinoma,
grade 3 (Initial presentation).
Case 4: A 76 year old male patient presenting with left
sided neck swellings of insidious onset. No known primary
(Fig. 5).
MR ﬁndings: Enlarged left upper and lower deep cervical
lymph nodes: largest in level III showing lobulated smooth
contours.
Size: 2.3 cm in its shortest transverse diameter.
Parenchymal architecture: They show isointense T1 signal
changing into high T2 signal with faint homogenous contrast
uptake.
On DWIs: In DWIs: b0 and b1000, they are partially hyper-
intense corresponding to lymph nodes of low signal in ADC
map.
ADC value: 0.57 · 103 mm2/s.
Suggested MR diagnosis: Malignant lymphadenopathy.
Biopsy results: Non Hodgkin lymphoma.
Case 5: A 55 year old male presenting with left sided retro-
molar malignant mass of insidious onset. MRI neck was done
for staging (Fig. 6).
MR ﬁndings: Left upper deep cervical lymph node level Ib
showing smooth contour.Size: 0.7 cm in its shortest transverse diameter.
Parenchymal architecture: It shows isointense T1 signal
changing into high T2 signal with fair homogenous contrast
uptake.
On DWIs: In DWIs: b0 and b1000, it shows hyperintense
signal corresponding to lymph node of low signal in ADC
map.
ADC value: 0. 834 · 103 mm2/s.
Suggested MR diagnosis: Malignant lymphadenopathy.
Biopsy results: Metastatic SCC.
Conﬂict of interest
Evaluation of the role of diffusion weighted MRI in the eval-
uation of cervical lymphadenopathy trying to differentiate
benign from malignant nodes.References
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